Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Rheumatoid Arthritis

  Free Subscription


03.04.2017

4 Ann Rheum Dis
2 Arthritis Res Ther
3 Clin Exp Rheumatol
4 Clin Rheumatol
2 Drugs
1 Scand J Rheumatol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Rheum Dis

  1. CHATZIDIONYSIOU K, Emamikia S, Nam J, Ramiro S, et al
    Efficacy of glucocorticoids, conventional and targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis.
    Ann Rheum Dis. 2017 Mar 29. pii: annrheumdis-2016-210711.
    PubMed     Text format     Abstract available

  2. MISRA DP, Agarwal V, Sharma A, Wakhlu A, et al
    2016 update of the EULAR recommendations for the management of rheumatoid arthritis: a utopia beyond patients in low/middle income countries?
    Ann Rheum Dis. 2017 Mar 27. pii: annrheumdis-2017-211446.
    PubMed     Text format    

  3. HUMPHREYS JH, Warner A, Costello R, Lunt M, et al
    Quantifying the hepatotoxic risk of alcohol consumption in patients with rheumatoid arthritis taking methotrexate.
    Ann Rheum Dis. 2017 Mar 23. pii: annrheumdis-2016-210629.
    PubMed     Text format     Abstract available

  4. MANIVEL VA, Mullazehi M, Padyukov L, Westerlind H, et al
    Anticollagen type II antibodies are associated with an acute onset rheumatoid arthritis phenotype and prognosticate lower degree of inflammation during 5 years follow-up.
    Ann Rheum Dis. 2017 Mar 23. pii: annrheumdis-2016-210873.
    PubMed     Text format     Abstract available


    Arthritis Res Ther

  5. MENG W, Zhu Z, Jiang X, Too CL, et al
    DNA methylation mediates genotype and smoking interaction in the development of anti-citrullinated peptide antibody-positive rheumatoid arthritis.
    Arthritis Res Ther. 2017;19:71.
    PubMed     Text format     Abstract available

  6. ALBRECHT K, Zink A
    Poor prognostic factors guiding treatment decisions in rheumatoid arthritis patients: a review of data from randomized clinical trials and cohort studies.
    Arthritis Res Ther. 2017;19:68.
    PubMed     Text format     Abstract available


    Clin Exp Rheumatol

  7. AVILA-RIBEIRO P, Brault Y, Dougados M, Gossec L, et al
    Psychometric properties of sleep and coping numeric rating scales in rheumatoid arthritis: a subanalysis of an etanercept trial.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available

  8. KURIYA B, Schieir O, Lin D, Xiong J, et al
    Thresholds for the 28-joint disease activity score (DAS28) using C-reactive protein are lower compared to DAS28 using erythrocyte sedimentation rate in early rheumatoid arthritis.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available

  9. YANG M, Galebach PJ, Signorovitch JE, Garg V, et al
    Effectiveness and healthcare costs among stabilised rheumatoid arthritis patients with dose reduction of adalimumab or etanercept in real world.
    Clin Exp Rheumatol. 2017.
    PubMed     Text format     Abstract available


    Clin Rheumatol

  10. MURALIDHARAN N, Misra DP, Jain VK, Negi VS, et al
    Effect of thymidylate synthase (TYMS) gene polymorphisms with methotrexate treatment outcome in south Indian Tamil patients with rheumatoid arthritis.
    Clin Rheumatol. 2017 Mar 27. doi: 10.1007/s10067-017-3608.
    PubMed     Text format     Abstract available

  11. LI C, Wang XR, Ji HJ, Zhang XY, et al
    Cardiovascular disease in rheumatoid arthritis: medications and risk factors in China.
    Clin Rheumatol. 2017 Mar 24. doi: 10.1007/s10067-017-3596.
    PubMed     Text format     Abstract available

  12. RAMIREZ-PEREZ S, Salazar-Paramo M, Pineda-Monjaras S, De la Cruz-Mosso U, et al
    Association of 86 bp variable number of tandem repeat (VNTR) polymorphism of interleukin-1 receptor antagonist (IL1RN) with susceptibility and clinical activity in rheumatoid arthritis.
    Clin Rheumatol. 2017 Mar 25. doi: 10.1007/s10067-017-3610.
    PubMed     Text format     Abstract available

  13. CUOMO G, D'Abrosca V, Iacono D, Pantano I, et al
    Erratum to: The conversion rate of tuberculosis screening tests during biological therapies in patients with rheumatoid arthritis.
    Clin Rheumatol. 2017 Mar 28. doi: 10.1007/s10067-017-3614.
    PubMed     Text format    


    Drugs

  14. GECSE KB, Lakatos PL
    Biosimilar Monoclonal Antibodies for Inflammatory Bowel Disease: Current Comfort and Future Prospects.
    Drugs. 2016.
    PubMed     Text format     Abstract available

  15. BRITO-ZERON P, Retamozo S, Gheitasi H, Ramos-Casals M, et al
    Treating the Underlying Pathophysiology of Primary Sjogren Syndrome: Recent Advances and Future Prospects.
    Drugs. 2016;76:1601-1623.
    PubMed     Text format     Abstract available


    Scand J Rheumatol

  16. LESUIS N, Verhoef LM, Nieboer LM, Bruyn GA, et al
    Implementation of protocolized tight control and biological dose optimization in daily clinical practice: results of a pilot study.
    Scand J Rheumatol. 2017;46:152-155.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: